top of page
Josh Headshot.jpg
Josh Pan, PhD MBA
Business Development

Josh is a biotech and startup executive with over 10 years of experience in the industry. He has served in roles of increasing responsibility at Athira Pharma, Inc. (Nasdaq: ATHA) from 2015 to July 2023 supporting business development, corporate development, corporate communications, medical affairs, product commercialization and corporate financing from 2015 through to its IPO in September 2020; his latest appointment with Athira was Vice President of Corporate Development and External Affairs. Josh is Founder and Principal of S-Phase Ventures, LLC, a boutique strategy, operations and business development consultancy for start-ups, venture funds, and non-profit organizations since 2015. He has been an advisor to Bellevue Capital Management (BCM) since March 2015, and starting in June 2018, has served as a consultant to BCM. In August 2020, he became a member of BCM as a Partner. Josh has also held appointments as Associate and later, Interim Chief Operating Officer for W Fund, a Seattle, Washington-based early-stage venture fund from 2013-2015.

 

Josh earned a BS in Chemistry from Oregon State University (2004). He then earned an MBA (2011) and PhD in Molecular and Cellular Biology (2012) from the University of Washington.

1.jpg

Numiera Therapeutics Inc

225 S Broadway 9533

Denver CO 80209-9998

©2024 Numiera Therapeutics

bottom of page